NCT06334237

Brief Summary

This research project aims at exploring the psychosomatic factors that influence and moderate the efficacy of holistic care and personalized treatment for migraine patients. It is a prospective longitudinal observational study. The project's goal is to understand how physical, psychological, spiritual, and social factors affect the care and treatment outcomes for migraineurs. The study will include participants aged 18 to 65, who meet the International Headache Society's criteria for migraines. It will utilize a range of methodologies including questionnaires, interviews, and medical records to collect data on various factors like lifestyle, psychological state, and social support. The project will assess the effectiveness of treatments, compliance, and other outcomes such as emotional and sleep conditions.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 1, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 27, 2024

Completed
22 days until next milestone

Study Start

First participant enrolled

April 18, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 21, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 21, 2026

Completed
Last Updated

May 24, 2024

Status Verified

May 1, 2024

Enrollment Period

10 months

First QC Date

February 1, 2024

Last Update Submit

May 22, 2024

Conditions

Keywords

migraineholistic carepersonalized treatment

Outcome Measures

Primary Outcomes (4)

  • Migraine attack frequency

    The frequency of migraine attacks will be assessed by the number of days with migraine attacks recorded in the migraine diary.

    3 months

  • Migraine attack intensity

    The intensity of migraine attacks will be assessed by the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst pain imaginable). Higher scores indicate greater pain intensity.

    3 months

  • Migraine attack duration

    The duration of each migraine attack will be recorded in the migraine diary, measured in hours.

    3 months

  • Effectiveness of acute medication

    The effectiveness of acute medication will be assessed by a 4-point scale measuring the degree of pain relief after medication administration, recorded in the migraine diary: 1. No effect at all 2. Minimal effect, headache slightly improved 3. Good effect, headache significantly improved 4. Very effective, pain completely resolved

    3 months

Secondary Outcomes (6)

  • Compliance rate of migraine diary

    3 months

  • Compliance rate of lifestyle modification

    3 months

  • depression

    3 months

  • anxiety

    3 months

  • well-being

    3 months

  • +1 more secondary outcomes

Interventions

According to the condition of each individuals, the study continues their routine clinical care. The study does not offer anything more than a routine clinical care. It is named personalized treatment because the condition of each individual varies, so the doctor may prescribe or offer clinical advice accordingly. .

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

participants aged 18 to 65 who meet the International Headache Society's criteria for migraines.

You may qualify if:

  • individuals aged between 18 and 65 who meet the International Headache Society's criteria for migraines

You may not qualify if:

  • incapacitate such as dementia or cognitive deficiency
  • illiterate, or could not sign informed consents
  • severe disorder or co-morbidities that the doctors advice against participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Changhua Christian Hospital

Chang-hua, 500, Taiwan

RECRUITING

MeSH Terms

Conditions

Migraine Disorders

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 1, 2024

First Posted

March 27, 2024

Study Start

April 18, 2024

Primary Completion

February 21, 2025

Study Completion

February 21, 2026

Last Updated

May 24, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Since the research data contains medical records, we do not plan to share it.

Locations